Michael Feely
Overview
Explore the profile of Michael Feely including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
175
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dashti N, Swanson A, Patel V, Xing D, Feely M, Keeney G, et al.
Int J Gynecol Pathol
. 2024 Sep;
PMID: 39230557
No abstract available.
2.
Ozer M, Goksu S, Lin R, Ayasun R, Kahramangil D, Rogers S, et al.
J Hepatocell Carcinoma
. 2023 Jul;
10:1129-1141.
PMID: 37489126
Background: Advanced hepatocellular carcinoma (HCC) generally has a dismal prognosis. Bone metastases from HCC are infrequent, with a poorer prognosis. However, the survival influencing factors are not yet well understood....
3.
Guijarro M, Nawab A, Dib P, Burkett S, Luo X, Feely M, et al.
Oncogene
. 2023 Apr;
42(23):1926-1939.
PMID: 37106126
We previously showed that elevated TYMS exhibits oncogenic properties and promotes tumorigenesis after a long latency, suggesting cooperation with sequential somatic mutations. Here we report the cooperation of ectopic expression...
4.
Guijarro M, Kellish P, Dib P, Paciaroni N, Nawab A, Andring J, et al.
JCI Insight
. 2023 Apr;
8(10).
PMID: 37097751
Although thymidylate synthase (TYMS) inhibitors have served as components of chemotherapy regimens, the currently available inhibitors induce TYMS overexpression or alter folate transport/metabolism feedback pathways that tumor cells exploit for...
5.
Altshuler E, Franke A, Skelton 4th W, Feely M, Wang Y, Lee J, et al.
Clin Colorectal Cancer
. 2022 Nov;
22(1):153-159.
PMID: 36319582
Introduction: DNA mismatch repair deficient (dMMR) or microsatellite instability-high (MSI-H) colorectal cancer (CRC) is found in about 15% of early-stage diseases and 5% of metastatic diseases. We reviewed a large,...
6.
Vijayakurup V, Maeng K, Lee H, Meyer B, Burkett S, Nawab A, et al.
JCI Insight
. 2022 Sep;
7(19).
PMID: 36048542
Clinical studies of cancer patients have shown that overexpression or amplification of thymidylate synthase (TS) correlates with a worse clinical outcome. We previously showed that elevated TS exhibits properties of...
7.
Kilzer A, Klingemann L, Mikuls T, Thiele G, Petro A, Feely M
Exp Clin Transplant
. 2022 May;
20(12):1122-1125.
PMID: 35607800
Refractory gout can be treated with infusions of pegloticase, which metabolizes uric acid into a product readily excreted in urine. Antidrug antibodies often develop, leading to reduced efficacy and potential...
8.
Feely M, Tondon R, Gubbiotti M, Stashek K, Numbere N, Huber A, et al.
Am J Surg Pathol
. 2022 Apr;
46(9):1234-1240.
PMID: 35389897
Radioembolization therapy utilizes yttrium-90 (Y90) impregnated resin (SIR-Spheres) or glass (TheraSpheres) microspheres to selectively target hepatic lesions via transarterial radioembolization. Occasional cases of gastrointestinal tract injury, secondary to nontargeted delivery...
9.
Disseminated genitourinary histoplasmosis in a patient with AIDS with negative urine antigen testing
Joseph C, Feely M, Iovine N
BMJ Case Rep
. 2021 Nov;
14(11).
PMID: 34772673
Disseminated histoplasmosis is a life-threatening condition in immunocompromised patients. The majority of healthy persons have benign disease not requiring treatment. However, in persons living with HIV, mortality is high and...
10.
Vehicle Control as a Measure of Real-World Driving Performance in Patients With Rheumatoid Arthritis
Mikuls T, Merickel J, Gwon Y, Sayles H, Petro A, Cannella A, et al.
Arthritis Care Res (Hoboken)
. 2021 Aug;
75(2):252-259.
PMID: 34397172
Objective: To quantify vehicle control as a metric of automobile driving performance in patients with rheumatoid arthritis (RA). Methods: Naturalistic driving assessments were completed in patients with active RA and...